Literature DB >> 3565933

Induction of pulmonary inflammation by components of the pneumococcal cell surface.

E Tuomanen, R Rich, O Zak.   

Abstract

Using a rabbit model of experimental pneumonitis, the components on the surface of the pneumococcus that incite pulmonary inflammation were identified. Rabbits were challenged intratracheally with live pneumococci, capsular polysaccharide, purified cell walls, or cell wall subcomponents. Leukocytosis and elevation of protein concentration was quantitated in bronchial lavage fluid during the first 24 h after challenge. Of the pneumococcal surface components tested, cell wall preparations had the highest specific activity in inducing inflammation; abnormalities in bronchial lavage fluid cytochemistry appeared rapidly and in a dose-dependent manner. Cell wall building blocks and the products of penicillin-induced hydrolysis of the cell wall were also highly inflammatory, indicating that inflammation can be generated by disruption of the cell wall during lysis of bacteria by beta-lactam antibiotics. Administration of inhibitors of arachidonic acid metabolism suggested that inhibition of the lipoxygenase pathway reduced inflammation associated with cell walls. We propose that pulmonary inflammation during pneumococcal pneumonia arises in large part from the interaction of the bacterial cell wall with complement and noncomplement-mediated host defenses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3565933     DOI: 10.1164/arrd.1987.135.4.869

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  37 in total

Review 1.  Streptococcus pneumoniae.

Authors:  J R Catterall
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.

Authors:  Aras Kadioglu; William Coward; M Joseph Colston; Colin R A Hewitt; Peter W Andrew
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

3.  Pneumococcal antigens and serum antibody responses in experimentally induced sinusitis.

Authors:  K M Westrin; A Freijd; P Stierna
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

4.  Western blot analysis of immunoglobulin G antibodies to pneumococcal protein antigens in healthy adults.

Authors:  J Renneberg; M Svinhufvud; K Prellner; P Christensen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

5.  Allelic variation in Streptococcus pneumoniae autolysin (N-acetyl muramoyl-L-alanine amidase).

Authors:  S H Gillespie; T D McHugh; H Ayres; A Dickens; A Efstratiou; G C Whiting
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

6.  Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components.

Authors:  I Riesenfeld-Orn; S Wolpe; J F Garcia-Bustos; M K Hoffmann; E Tuomanen
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

7.  Inhibition of human neutrophil migration in vitro by low-molecular-mass products of nontypeable Haemophilus influenzae.

Authors:  D R Cundell; G W Taylor; K Kanthakumar; M Wilks; S Tabaqchali; E Dorey; J L Devalia; D E Roberts; R J Davies; R Wilson
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

Review 8.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 9.  Acute otitis media with spontaneous tympanic membrane perforation.

Authors:  N Principi; P Marchisio; C Rosazza; C S Sciarrabba; S Esposito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-27       Impact factor: 3.267

10.  Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia.

Authors:  Silvia Fernández-Serrano; Jordi Dorca; Mercè Coromines; Jordi Carratalà; Francesc Gudiol; Frederic Manresa
Journal:  Clin Diagn Lab Immunol       Date:  2003-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.